Detalhe da pesquisa
1.
Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia.
Blood
; 143(23): 2363-2372, 2024 Jun 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38452207
2.
Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk.
Haematologica
; 105(9): e480-483, 2020 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33054068
3.
Comprehensive molecular landscape in patients older than 80 years old diagnosed with acute myeloid leukemia: A study of the French Hauts-de-France AML observatory.
Am J Hematol
; 94(1): E24-E27, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30358899
4.
Azacitidine in untreated acute myeloid leukemia: a report on 149 patients.
Am J Hematol
; 89(4): 410-6, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24375487
5.
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.
Blood
; 117(2): 403-11, 2011 Jan 13.
Artigo
Inglês
| MEDLINE | ID: mdl-20940414
6.
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte.
Blood
; 116(12): 2040-5, 2010 Sep 23.
Artigo
Inglês
| MEDLINE | ID: mdl-20548096
7.
The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively.
Cancers (Basel)
; 13(9)2021 04 29.
Artigo
Inglês
| MEDLINE | ID: mdl-33947035
8.
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial.
Leukemia
; 35(8): 2332-2345, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33483613
9.
Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study.
Cancers (Basel)
; 11(9)2019 Sep 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31500210
10.
Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis.
Cancer Genet Cytogenet
; 178(1): 11-6, 2007 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17889703
11.
Azacitidine for the treatment of relapsed and refractory AML in older patients.
Leuk Res
; 39(2): 124-30, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25524177
12.
Frequency of structural abnormalities of the long arm of chromosome 12 in myelofibrosis with myeloid metaplasia.
Cancer Genet Cytogenet
; 137(1): 68-71, 2002 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-12377417
13.
Chronic myeloproliferative disorder with t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic chronic myelogeneous leukemia.
Genes Chromosomes Cancer
; 47(10): 915-8, 2008 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-18615682
14.
Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry.
Orphanet J Rare Dis
; 7: 71, 2012 Sep 25.
Artigo
Inglês
| MEDLINE | ID: mdl-23009155
15.
Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia.
Genes Chromosomes Cancer
; 39(1): 82-7, 2004 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-14603445